Campbell & CO Investment Adviser LLC Takes Position in Waters Corporation $WAT

Campbell & CO Investment Adviser LLC bought a new stake in shares of Waters Corporation (NYSE:WAT) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 9,963 shares of the medical instruments supplier’s stock, valued at approximately $3,477,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Zions Bancorporation National Association UT purchased a new position in Waters during the first quarter valued at $28,000. IFP Advisors Inc raised its position in shares of Waters by 118.9% during the 1st quarter. IFP Advisors Inc now owns 81 shares of the medical instruments supplier’s stock worth $30,000 after purchasing an additional 44 shares during the last quarter. Caitong International Asset Management Co. Ltd purchased a new position in Waters in the 1st quarter valued at about $41,000. Creative Financial Designs Inc. ADV boosted its holdings in Waters by 533.3% in the 2nd quarter. Creative Financial Designs Inc. ADV now owns 190 shares of the medical instruments supplier’s stock worth $66,000 after buying an additional 160 shares during the last quarter. Finally, Steph & Co. purchased a new stake in Waters during the 2nd quarter worth approximately $73,000. Hedge funds and other institutional investors own 94.01% of the company’s stock.

Waters Trading Up 0.2%

WAT opened at $371.97 on Friday. The stock has a market capitalization of $22.15 billion, a PE ratio of 33.54, a P/E/G ratio of 3.19 and a beta of 1.11. Waters Corporation has a one year low of $275.05 and a one year high of $423.56. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.22 and a current ratio of 1.75. The business’s 50 day moving average price is $323.54 and its 200 day moving average price is $326.08.

Waters (NYSE:WAT) last posted its earnings results on Thursday, May 19th. The medical instruments supplier reported $2.29 EPS for the quarter. The company had revenue of $608.55 million for the quarter. Waters had a return on equity of 38.60% and a net margin of 21.71%. As a group, equities research analysts expect that Waters Corporation will post 12.86 EPS for the current year.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the company. UBS Group restated a “neutral” rating on shares of Waters in a research report on Tuesday, July 15th. Redburn Partners set a $390.00 price objective on Waters in a report on Wednesday, October 8th. TD Cowen upped their target price on shares of Waters from $345.00 to $390.00 and gave the stock a “hold” rating in a report on Wednesday. Deutsche Bank Aktiengesellschaft set a $315.00 target price on shares of Waters and gave the company a “hold” rating in a research report on Tuesday, August 5th. Finally, Rothschild & Co Redburn started coverage on shares of Waters in a research note on Wednesday, October 8th. They set a “buy” rating and a $390.00 price objective for the company. Two equities research analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating and nine have issued a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $381.57.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.